World Smart Money
US Markets
Themes
🧬

Genomics & Precision Medicine

Sequencers, reagents, single-cell & spatial, liquid biopsy, and AI drug discovery

Sequencing Platforms
SequencersSequencer platform war; cost-per-genome curve and installed base define the moat
Synthesis & Single-CellDNA synthesis & single-cell tools expand throughput β€” core research-end demand
Proteomics & SpatialProteomics & spatial biology open the post-sequencing growth frontier β€” still early-stage
Instruments & Reagents
Life-Science MajorsLife-science giants sell the picks β€” instrument base locks in razor-blade consumable annuities
Consumables & PackagingConsumables & CRO bioprocessing are recurring revenue β€” defensive, cash-generative
Protein & NA ReagentsHigh-margin protein/nucleic-acid reagents; proprietary process know-how is the barrier
Diagnostics & Testing
Liquid BiopsyLiquid biopsy targets the trillion-dollar early-detection TAM β€” reimbursement is the gating factor
Specialty Genomic DxSpecialty genetic tests monetize via guideline inclusion β€” volume and pricing both matter
Lab ServicesQuest/Labcorp lab duopoly β€” scale equals pricing power in routine diagnostics
AI Drug Discovery
AI-Bio PlatformsAI bio platforms compress discovery timelines β€” milestone delivery remains the key debate
Data & CRO
Clinical DataCRO & clinical-data SaaS own the trial-data backbone β€” high switching costs, sticky revenue

Theme lists curated by Claude and may have gaps; quotes live. Research only, not investment advice. Β· Updated 2026-06-28